Physician profile
Keith Atassi
NPI 1336160753
$33,338.26
in general payments reported to CMS, 2019-2025
55 companies · $4,123 in 2025
The $4,123 reported for 2025 was more than what 80% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $1,562 · 2021: $3,060 · 2022: $3,230 · 2023: $4,500 · 2024: $3,904 · 2025: $4,123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,172 · Travel and Lodging: $3,354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,171.73 |
| Travel and Lodging | $3,354.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $8,231.22 | 2019-2025 | Jardiance |
| Boston Scientific Corporation | $3,236.90 | 2019-2025 | Watchman Flx, General - Atherectomy, Enroute Transcarotid Stent |
| Abiomed | $2,840.19 | 2019-2025 | Impella |
| Medtronic, INC. | $2,167.69 | 2021-2025 | Symplicity G3, Abre, Corevalve Evolut R |
| Novartis Pharmaceuticals Corporation | $1,885.78 | 2019-2025 | |
| Medtronic Vascular, INC. | $1,652.91 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $1,296.94 | 2019-2025 | Farxiga, Wainua, Brilinta |
| Penumbra, INC. | $1,121.08 | 2024-2025 | Indigo System |
| Merck Sharp & Dohme LLC | $1,006.90 | 2021-2025 | Verquvo, Capvaxive |
| E.R. Squibb & Sons, L.L.C. | $934.51 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $873.27 | 2019-2024 | Xarelto |
| Amgen INC. | $790.51 | 2019-2025 | Repatha, Repatha |
| Esperion Therapeutics, INC. | $735.90 | 2020-2025 | Nexletol |
| Sanofi-Aventis U.S. LLC | $674.96 | 2019-2024 | |
| Endologix LLC | $673.19 | 2021-2023 | Ovation Ix Iliac Stent Graft |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $570.82 | 2019-2025 | |
| Chiesi USA, INC. | $520.33 | 2020-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $346.79 | 2019-2024 | Lifevest |
| Amarin Pharma, INC. | $344.92 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $316.52 | 2022-2025 | Uptravi, Opsumit |
| Aop Health US, LLC | $286.97 | 2025 | Rapiblyk |
| Abbott Laboratories | $240.53 | 2022-2025 | Esprit |
| Shockwave Medical, INC | $222.18 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $195.55 | 2022-2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Bayer Healthcare Pharmaceuticals INC. | $187.53 | 2021-2025 | |
| Edwards Lifesciences Corporation | $170.97 | 2020-2025 | Pascal |
| Scpharmaceuticals INC. | $165.98 | 2023-2025 | |
| Cook Medical LLC | $161.80 | 2019-2022 | |
| Silk Road Medical, INC. | $150.00 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Genzyme Corporation | $125.00 | 2019 | |
| Astellas Pharma US INC | $104.22 | 2019 | |
| Stryker Corporation | $101.80 | 2025 | Artix Mt |
| Gilead Sciences, INC. | $86.47 | 2019 | |
| Kiniksa Pharmaceuticals, Ltd. | $82.42 | 2021-2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $68.04 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $65.81 | 2023-2024 | Inpefa |
| Biosense Webster, INC. | $59.92 | 2019 | |
| Bard Peripheral Vascular, INC. | $58.83 | 2019 | |
| Axsome Therapeutics, INC. | $58.56 | 2023 | Auvelity |
| Heartflow, INC. | $49.52 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $47.58 | 2021-2022 | |
| Vifor Pharma, INC. | $45.94 | 2019 | |
| Teleflex LLC | $43.55 | 2025 | Guideliner, Manta |
| Novo Nordisk INC | $42.97 | 2025 | Wegovy |
| Arbor Pharmaceuticals, INC. | $38.49 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $36.76 | 2019 | |
| Philips North America LLC | $36.29 | 2020-2021 | |
| Abbvie INC. | $33.27 | 2025 | |
| Lundbeck LLC | $31.61 | 2019 | |
| Cardiovascular Systems INC. | $30.05 | 2022 | |
| Kestra Medical Technology Services, INC. | $23.31 | 2025 | Assure Wcd |
| Bsn Medical INC | $20.01 | 2019 | |
| Angiodynamics, INC. | $16.87 | 2019 | |
| Ekos Corporation | $16.75 | 2019 | |
| Tactile Systems Technology INC | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Atassi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.